Introduction
In developing countries, and particularly in Africa, poor sanitation exposes people to a wider array of microbial pathogens, increasing their susceptibility to bacterial infections (1) . Each year, 3 million children are reported to die of diarrheal diseases. Cholera is a leading diarrheal disease in terms of its severity and outcomes. Several epidemics of cholera have been reported in different parts of Cameroon and abroad (2) (3) (4) (5) . Vibrio cholerae strains belonging to the O1 and O139 serogroups cause epidemics and pandemics of cholera (6, 7) . Over the past few years, reported cases of cholera have increased steadily, numbering more than 300,000 cases and including more than 7,500 deaths in 2010 (8) . As populations of poor countries continue to coalesce in mega-cities with low levels of sanitation and people move rapidly around the globe, new and more virulent strains of V. cholerae are expected to disseminate more rapidly (9, 10) . This makes cholera one of the most rapidly fatal infectious illnesses known.
The continuous emergence of multi-drug-resistant (MDR) Vibrio cholerae strains drastically reduces the efficacy of our antibiotic armory and, consequently, increases the frequency of therapeutic failure (11, 12) . In many regions affected by this pathogen, local and indigenous plants are often the only available means of treating such infections. Among the known plant species on Earth (estimated at 250,000-500,000), only a small fraction have been investigated for the presence of antimicrobial compounds and only 1-10% of plants are used by humans (13, 14) . Natural plant products also act as antioxidants. These include phenolic compounds, alkaloids, terpenoids, and essential oils. Plant-based antioxidant compounds (15) play a defensive role by preventing the generation of free radicals and hence are extremely beneficial to alleviating infectious diseases that generate free radicals as well as diseases caused by oxidative stress such as cardiovascular diseases, diabetes, inflammation, degenerative diseases, cancer, anemia, and ischemia (16) .
Ludwigia leptocarpa (Nutt) Hara (Onagraceae or Oenotheraceae) is a herbaceous plant species that is also readily found in North America and in tropical Africa (17) . In traditional medicine in Nigeria, an infusion of the plant is part of a mixture used to treat rheumatism (18) . A leaf infusion has laxative, vermifugal, and antidysenteric properties. Previous studies of this genus have revealed the presence of flavonoids (19, 20) , cerebrosides, and triterpenoids (20, 21) . A study recently reported that alcoholic extracts of the leaves of L. octovalvis, L. abyssinica, and L. decurrens potentially have antioxidant, antibacterial, and antifungal activities (22, 23) . To the extent known, no study has reported on the antioxidant and antibacterial properties of L. leptocarpa with respect to bacterial strains causing diarrhea. Hence, the aim of this study was to investigate the antibacterial and antioxidant properties of extracts and compounds from L. leptocarpa.
Materials and Methods

Experimental
IR spectra were recorded with a Shimadzu FT-IR-8400S (Shimadzu, France) 
Extraction and isolation
Dried L. leptocarpa (4 kg) was extracted with MeOH at room temperature for 3 days, and the extract was concentrated to dryness under reduced pressure to yield a dark crude extract (102 g). Part of the residue obtained (97 g) was suspended in water (200 mL) and successively extracted with ethyl acetate (EtOAc) and n-butanol (n-BuOH). The result was concentrated to dryness under reduced pressure to respectively yield EtOAc (20 g) and n-BuOH (40 g) extracts.
In accordance with antimicrobial and antioxidant assays, the EtOAc and n-BuOH extracts were submitted to further separation and purification. Part of the EtOAc extract (15 g) was purified over a silica gel column and eluted with hexane containing increasing concentrations of EtOAc (10%, 20%, 30%, 40%, 50%, 60%, 70%, and 80%). The purified extracted was also eluted with EtOAc containing increasing concentrations of MeOH (10% and 20%). Six fractions were obtained: A, B, C, D, E, and F. Fraction D (1.7 g) was purified over a silica gel column and eluted with a hexane-EtOAc mixture (7:3) to yield compounds 1 and 2 (17 mg and 22 mg, 
Antibacterial assay
Microorganisms
A total of six bacterial strains were tested for their susceptibility to compounds and these strains were from our laboratory collection (kindly provided by Dr. T. Ramamurthy, NICED, Kolkata). Among the clinical strains of Vibrio cholerae used in this study, strain NB2 belongs to the O1 serotype and strain SG24(1) belongs to the O139 serotype. These strains are able to produce cholera toxin and hemolysin (24, 25) . The other strains used in this study were non-O1 and non-O139 strains of V. cholerae (strains CO6 and PC2) (24) and strains of Shigella flexneri (26) . The non-O1 and non-O139 strains of V. cholerae were positive for hemolysin production but negative for cholera toxin production (24) . An American Type Culture Collection (ATCC) strain of Staphylococcus aureus, ATCC 25923, was used for quality control. The bacterial strains were maintained on an agar slant at 4°C and subcultured on appropriate fresh agar plates 24 h prior to any antibacterial testing. Mueller Hinton Agar (MHA) was used to activate bacteria. Mueller Hinton Broth (MHB) was used to determine minimum inhibitory concentrations (MICs) and nutrient agar (HiMedia) was used to determine minimum bactericidal concentrations (MBCs).
Determination of MICs and MBCs
MICs and MBCs of extracts/compounds were assessed using the broth microdilution method recommended by the National Committee for Clinical Laboratory Standards (27,28) with slight modifications. Each test sample was dissolved in dimethylsulfoxide (DMSO, Fisher chemicals) to yield a stock solution. Ninetysix-well round-bottom sterile plates were prepared by dispensing 180 µL of the inoculated broth (1 × 10 6 CFU/ mL) into each well. A 20 µL aliquot of a compound was added. The concentration of the tested samples varied from 0.125 to 1,024 µg/mL. The final concentration of DMSO in each well was < 1% [preliminary analyses with 1% (v/v) DMSO did not inhibit the growth of the test organisms]. Dilutions of ampicillin (SigmaAldrich, Steinheim, Germany) and tetracycline (SigmaAldrich, Steinheim, Germany) served as positive controls, while broth with 20 µL of DMSO was used as a negative control. Plates were covered and incubated respectively). Fraction E (3.1 g) was purified over a silica gel column and eluted with a hexane-EtOAc mixture (6:4) to yield compound 3 (17 mg). Part of the n-BuOH extract (30 g) was purified over a silica gel column and eluted with EtOAc containing increasing concentrations of MeOH (10%, 20%, 30%, 40%, and 50%). Five fractions (G 1 -G 5 ) were obtained. Fraction G 1 (2.5 g) was purified over a silica gel column and eluted with EtOAc to yield the compounds 4 (19 mg) and 5 (16 mg). Fraction G 2 (3.1 g) was purified over a silica gel column and eluted with an EtOAc-MeOH mixture (8.5:1.5) to yield compounds 5 (25 mg) and 6 (13 mg). Fractions G 3 and G 4 (5.4 g) were combined and purified over a silica gel column; the fractions were then eluted with an EtOAc-MeOH-H2O mixture (8:1:1) to yield the compounds 7 (38 mg) and 8 (24 mg). Fraction G5 (2.5 g) was purified over a silica gel column and eluted with an EtOAc-MeOH-H 2 O mixture (7:2:1) to yield the compounds 9 (66 mg) and 10 (40 mg).
Oleanolic acid (1) 3 3 Here, A 0 is the absorbance of the control and A 1 is the absorbance in the presence of the sample. The IC 50 was determined from a graph obtained using standard vitamin C by using the formula "y = mx + c" for the slope of the graph.
Gallic acid equivalent antioxidant capacity (GAEAC) assay
A GAEAC assay was performed as previously described (30) with slight modifications. In a quartz cuvette, 20 µL of laccase (1 mM stock solution), 20 µL of a test sample, and 10 µL of ABTS (2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (74 mM of stock solution) were added to 950 µL of an acetate buffer (pH = 5.0, 100 mM). The laccase was purified from Sclerotinia sclerotiorum according to a previously described protocol (31) . The sample concentrations in the assay mixture were 800, 400, 200, 100, and 10 µg/mL for the extracts and 200, 100, 50, 25, and 125.5 µg/mL for the isolated compounds. The content of the generated ABTS •+ radical was measured at 420 nm after reaction for 240 s and this measurement was converted to the gallic acid equivalent using a calibration curve (Pearson's correlation coefficient: r = 0.996) created with 0, 4, 10, 14, 28, 56, and 84 µM of gallic acid rather than Trolox. Experiments were done in triplicate.
Statistical analysis
Data were analyzed using one-way analysis of variance followed by the Waller-Duncan post-hoc test. Results are expressed as the mean ± standard deviation (SD). p <0.05 was considered to indicate a significant difference. All analyses were performed using the software Statistical Package for Social Sciences (SPSS, version 12.0).
Results and Discussion
Chemical analysis
In accordance with antibacterial assays of the MeOH, EtOAc, and n-BuOH extracts, the EtOAc and n-BuOH extracts were further separated and purified. This led to the isolation of 10 compounds. Structures ( Figure  1 ) of these compounds have been assigned on the basis of spectroscopic data ( 1 H and 13 C NMR, 1 H-1 H COSY, HSQC, HMBC, ROESY, and NOESY), mass spectra, and by comparison of those compounds to compounds described in the literature. Hence, the isolated compounds were identified as oleanolic acid (1) (32); 2β-hydroxyoleanolic acid (2) (32); (2R,3S,2''S)-3''',4',4''',5,5'',7,7''-heptahydroxy-3,8"-biflavanone (3) (33); ellagic acid (4) (34); 3-O-β-D-glucopyranosyl-β-sitosterol (5) (35); luteolin-8-C-glucoside (6) (36) (10) (21).
Antibacterial activity
The susceptibility pattern and inhibition parameters of the tested organisms to the extracts and isolated compounds are indicated below (Table 1) . Wells containing a concentration of 64-512 μg/mL of MeOH, EtOAc, and n-BuOH extracts inhibited the visible growth of all bacterial species. The most sensitive bacterial species were S. aureus and S. flexneri, while V. cholerae SG24 (1) and V. cholerae NB2 were the species that were most resistant to the tested samples. All 3 plant extracts displayed less antibacterial activity than tetracycline. However, these extracts were active against V. cholerae NB2, V. cholerae PC2, and S. flexneri which were not sensitive to ampicillin. The antimicrobial activity of a plant extract was considered to be good if its MIC was less than 100.0 μg/mL, moderate if its MIC was from 100.0 to 500.0 μg/mL and poor if its MIC was over 500.0 μg/mL (37) . Hence, the MeOH, EtOAc, and n-BuOH extracts of L. leptocarpa exhibited good activity against S. aureus, with an MIC of 64 μg/mL, whereas only the MeOH extract displayed poor activity against V. cholerae SG24(1). The present results for extracts of L. leptocarpa indicated that this plant species is a potential source of antibacterial agents. This in vitro study corroborated a previous study that found that alcoholic extracts of L. octovalvis, L. abyssinica, and L. decurrens leaves inhibited Staphylococcus aureus (22, 23, 38) .
Compound 3 had the lowest MICs and MBCs, 2 μg/mL, for S. aureus; this compound has promise as an antibacterial since it was more potent at inhibiting S. aureus than the reference antibacterials ampicillin (MIC of 16 μg/mL and MBC of 16 μg/mL) and tetracycline (MIC of 16 μg/mL and MBC of 128 μg/mL) were. However, a MeOH extract had the highest MIC, 512 μg/mL, for V. cholerae SG24(1) while a MeOH extract had the highest MBC, 512 μg/mL, for V. cholerae SG24(1), V. cholerae CO6, and V. cholerae PC2. A lower MBC or MIC (≤ 4) means that a minimum amount of the plant extract or isolated compound was needed to kill the bacterial species while a higher value means that a comparatively higher concentration of the extract or compound was needed to control of the microorganism (39) .
Ranked in order of antibacterial activity, compound 3 isolated from L. leptocarpa had the most potent antibacterial activity, followed by compound 6, compound 2, compound 4, compounds 8 and 9, compound 10, compound 7, and then compound 1. Compounds 3, 6, 2, 4, 8, 9 , and 10 were active against all of the tested pathogens whereas compound 1 was active only against S. flexneri and S. aureus. No activity was noted for compound 5 (results not shown). Antimicrobial cut-off points have been defined by several authors to enable an understanding of the antimicrobial potential of pure compounds. Activity of a compound is classified as: significant activity (MIC < 10 µg/mL), moderate activity (10 < MIC ≤ 100 µg/mL), and low activity (MIC> 100 µg/mL) (40, 41) . Accordingly, compound 3 had significant antibacterial activity against V. cholerae CO6, V. cholerae NB2, V. cholerae PC2, S. flexneri, and S. aureus while compound 6 had significant antibacterial activity against Shigella flexneri SDINT and Staphylococcus aureus ATCC 25923. The strains of V. cholerae NB2, PC2 (24, 25) and Shigella flexneri (26) included in the present study were MDR clinical isolates and these were resistant to commonly used drugs such as ampicillin, streptomycin, tetracycline, nalidixic acid, furazolidone, and co-trimoxazole. However, most of the tested samples displayed antibacterial activity against these microbial strains, suggesting that their administration may represent an alternative treatment for V. cholerae, the cause of the dreadful disease cholera, and S. flexneri, the cause of shigellosis. Given the medical importance of the tested bacteria, the present results offer promise in terms of developing new antibacterials. The antibacterial activity of oleanolic acid, ellagic acid, and 2β-hydroxyoleanolic acid coincide with previous findings (42, 43) . All of the compounds that were found to be active in the present study are members of the triterpenoid, flavonoid, and phenolic acid groups. Although triterpenoid, flavonoid, and phenolic acid compounds have been reported to possess antibacterial activity (39, 44) , no study has reported the activity of compounds 3 and 6-10 on the types of MDR pathogenic bacterial strains used in the present study.
The mechanism of action of terpenoids (1, 2, 5, and 7-10) is not fully understood, but it may involve membrane disruption by lipophilic compounds (45) . Inhibition of the tested bacterial strains by phenolic acid (4) may be due to iron deprivation or hydrogen bounding with vital proteins such as microbial enzymes (46) . The mechanism of action of flavonoids (3 and 6) is still to be studied; nevertheless, their activity is probably due to their ability to form complexes with extracellular and soluble proteins and to form complexes with bacterial cell wall components. Moreover, lipophilic flavonoids may also disrupt microbial membranes (47).
Antioxidant activity
The MeOH, EtOAc, and n-BuOH extracts and their isolated compounds were evaluated for their antioxidant activity using two in vitro models. The results were expressed as the gallic acid equivalent antioxidant capacity of tested samples ( Figure 2 ) and as equivalent concentrations of test samples scavenging 50% of the DPPH radical (Figure 3) . DPPH
• and ABTS •+ radical scavenging activity were observed in all of the extracts. The MeOH and EtOAc extracts showed the most potent activity, followed by the n-BuOH extract (Figures 2  and 3) . These results indicate the potential of the tested extracts to serve as a natural source of antioxidants with the potential to reduce oxidative stress and provide subsequent health benefits. The antioxidant capacity of the tested extracts may be due to the hydrogendonating ability of phenols and flavonoids present in those extracts. Similarly, previous studies have reported that phenolic compounds contribute significantly to the antioxidant activity of medicinal plants (39, 48) . The compounds that had the most potent DPPH
• and ABTS
•+ radical scavenging activity were compounds 2 (EC 50 = 7.66 µg/mL; GAEAC= 71.64 µg/mL), 3 (EC 50 = 1.09 µg/mL; GAEAC= 96.88 µg/mL), and 6 (EC 50 = 10.34 µg/mL; GAEAC= 67.35 µg/mL), while the other compounds (compounds 4 and 8) had moderate antioxidant properties. Compounds 1, 5, 7, 9, and 10 were found to be inactive in both models. Compound 3 was the most potent antioxidant compound and its DPPH
• radical scavenging activity was equal to that of vitamin C, which was used in the present study as reference antioxidant. This finding suggests that compound 3 is the best candidate to combat diseases associated with oxidative stress. This is very promising in terms of discovering antioxidants from plants. The antioxidant activity of compounds 2 and 4 agreed with previously reported findings (42, 49) . However, the present study is the first to document the antioxidant activity of the MeOH, EtOAc and n-BuOH extracts of L. leptocarpa as well as that of compounds 3, 6, and 8.
Conclusion
Results indicated that MeOH and EtOAc extracts of L. leptocarpa as well as compounds 2, 3, and 6 possess the most potent antibacterial and antioxidant properties among the tested extracts and compounds. L. leptocarpa has the potential to be a natural source of products with health benefits, so it warrants further investigation. 
